These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32865790)

  • 21. Evaluation of Phosphorus and Non-Phosphorus Neutral Oligonucleotide Backbones for Enhancing Therapeutic Index of Gapmer Antisense Oligonucleotides.
    Vasquez G; Migawa MT; Wan WB; Low A; Tanowitz M; Swayze EE; Seth PP
    Nucleic Acid Ther; 2022 Feb; 32(1):40-50. PubMed ID: 34698585
    [TBL] [Abstract][Full Text] [Related]  

  • 22. mRNA levels can be reduced by antisense oligonucleotides via no-go decay pathway.
    Liang XH; Nichols JG; Hsu CW; Vickers TA; Crooke ST
    Nucleic Acids Res; 2019 Jul; 47(13):6900-6916. PubMed ID: 31165876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of palmitic acid-conjugated antisense oligonucleotide distribution in mice.
    Chappell AE; Gaus HJ; Berdeja A; Gupta R; Jo M; Prakash TP; Oestergaard M; Swayze EE; Seth PP
    Nucleic Acids Res; 2020 May; 48(8):4382-4395. PubMed ID: 32182359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Palmitic acid conjugation enhances potency of tricyclo-DNA splice switching oligonucleotides.
    Relizani K; Echevarría L; Zarrouki F; Gastaldi C; Dambrune C; Aupy P; Haeberli A; Komisarski M; Tensorer T; Larcher T; Svinartchouk F; Vaillend C; Garcia L; Goyenvalle A
    Nucleic Acids Res; 2022 Jan; 50(1):17-34. PubMed ID: 34893881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure Activity Relationships of α-L-LNA Modified Phosphorothioate Gapmer Antisense Oligonucleotides in Animals.
    Seth PP; Jazayeri A; Yu J; Allerson CR; Bhat B; Swayze EE
    Mol Ther Nucleic Acids; 2012 Sep; 1(10):e47. PubMed ID: 23344239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index.
    Shen W; De Hoyos CL; Migawa MT; Vickers TA; Sun H; Low A; Bell TA; Rahdar M; Mukhopadhyay S; Hart CE; Bell M; Riney S; Murray SF; Greenlee S; Crooke RM; Liang XH; Seth PP; Crooke ST
    Nat Biotechnol; 2019 Jun; 37(6):640-650. PubMed ID: 31036929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice.
    Prakash TP; Graham MJ; Yu J; Carty R; Low A; Chappell A; Schmidt K; Zhao C; Aghajan M; Murray HF; Riney S; Booten SL; Murray SF; Gaus H; Crosby J; Lima WF; Guo S; Monia BP; Swayze EE; Seth PP
    Nucleic Acids Res; 2014 Jul; 42(13):8796-807. PubMed ID: 24992960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted Delivery of Antisense Oligonucleotides Using Neurotensin Peptides.
    Nikan M; Tanowitz M; Dwyer CA; Jackson M; Gaus HJ; Swayze EE; Rigo F; Seth PP; Prakash TP
    J Med Chem; 2020 Aug; 63(15):8471-8484. PubMed ID: 32677436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the effects of chemically different linkers on hepatic accumulations, cell tropism and gene silencing ability of cholesterol-conjugated antisense oligonucleotides.
    Wada S; Yasuhara H; Wada F; Sawamura M; Waki R; Yamamoto T; Harada-Shiba M; Obika S
    J Control Release; 2016 Mar; 226():57-65. PubMed ID: 26855051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface Plasmon Resonance Assay of Binding Properties of Antisense Oligonucleotides to Serum Albumins and Lipoproteins.
    Onishi R; Watanabe A; Nakajima M; Sekiguchi M; Kugimiya A; Kinouchi H; Nihashi Y; Kamimori H
    Anal Sci; 2015; 31(12):1255-60. PubMed ID: 26656814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gapmer Antisense Oligonucleotides to Selectively Suppress the Mutant Allele in COL6A Genes in Dominant Ullrich Congenital Muscular Dystrophy.
    Aguti S; Marrosu E; Muntoni F; Zhou H
    Methods Mol Biol; 2020; 2176():221-230. PubMed ID: 32865794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Propensities of Fatty Acid-Modified ASOs: Self-Assembly vs Albumin Binding.
    Kusznir EA; Hau JC; Portmann M; Reinhart AG; Falivene F; Bastien J; Worm J; Ross A; Lauer M; Ringler P; Sladojevich F; Huber S; Bleicher K; Keller M
    Bioconjug Chem; 2023 May; 34(5):866-879. PubMed ID: 37145959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oligonucleotides Containing C5-Propynyl Modified Arabinonucleic Acids: Synthesis, Biophysical and Antisense Properties.
    Pontarelli A; Wilds CJ
    Chembiochem; 2023 May; 24(9):e202300068. PubMed ID: 36857293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical pharmacokinetics of second generation antisense oligonucleotides.
    Yu RZ; Grundy JS; Geary RS
    Expert Opin Drug Metab Toxicol; 2013 Feb; 9(2):169-82. PubMed ID: 23231725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Combination of Mesyl-Phosphoramidate Inter-Nucleotide Linkages and 2'-
    Zhang L; Liang XH; De Hoyos CL; Migawa M; Nichols JG; Freestone G; Tian J; Seth PP; Crooke ST
    Nucleic Acid Ther; 2022 Oct; 32(5):401-411. PubMed ID: 35861704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Next-Generation Peptide Nucleic Acid Chimeras Exhibit High Affinity and Potent Gene Silencing.
    Debacker AJ; Sharma VK; Meda Krishnamurthy P; O'Reilly D; Greenhill R; Watts JK
    Biochemistry; 2019 Feb; 58(6):582-589. PubMed ID: 30520300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ribonuclease H1-dependent hepatotoxicity caused by locked nucleic acid-modified gapmer antisense oligonucleotides.
    Kasuya T; Hori S; Watanabe A; Nakajima M; Gahara Y; Rokushima M; Yanagimoto T; Kugimiya A
    Sci Rep; 2016 Jul; 6():30377. PubMed ID: 27461380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotides.
    Iwamoto N; Butler DCD; Svrzikapa N; Mohapatra S; Zlatev I; Sah DWY; Meena ; Standley SM; Lu G; Apponi LH; Frank-Kamenetsky M; Zhang JJ; Vargeese C; Verdine GL
    Nat Biotechnol; 2017 Sep; 35(9):845-851. PubMed ID: 28829437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T7 Peptide-Conjugated Lipid Nanoparticles for Dual Modulation of Bcl-2 and Akt-1 in Lung and Cervical Carcinomas.
    Cheng X; Yu D; Cheng G; Yung BC; Liu Y; Li H; Kang C; Fang X; Tian S; Zhou X; Liu Q; Lee RJ
    Mol Pharm; 2018 Oct; 15(10):4722-4732. PubMed ID: 30138565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bolaamphiphile-based nanocomplex delivery of phosphorothioate gapmer antisense oligonucleotides as a treatment for Clostridium difficile.
    Hegarty JP; Krzeminski J; Sharma AK; Guzman-Villanueva D; Weissig V; Stewart DB
    Int J Nanomedicine; 2016; 11():3607-19. PubMed ID: 27536102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.